These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27478959)

  • 1. Effective transdermal delivery of methotrexate through nanostructured lipid carriers in an experimentally induced arthritis model.
    Garg NK; Singh B; Tyagi RK; Sharma G; Katare OP
    Colloids Surf B Biointerfaces; 2016 Nov; 147():17-24. PubMed ID: 27478959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
    Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
    Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Delivery of Aceclofenac and Methotrexate Nanoparticles Presents an Effective Treatment for Rheumatoid Arthritis.
    Negi S; Tandel N; Garg NK; Sharma P; Kumar R; Sharma P; Kumar R; Saini S; Sharma A; Tyagi RK
    Int J Nanomedicine; 2024; 19():2149-2177. PubMed ID: 38482519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
    Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
    Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery.
    Lee SW; Kim JH; Park MC; Park YB; Chae WJ; Morio T; Lee DH; Yang SH; Lee SK; Lee SK; Lee SK
    Biomaterials; 2012 Feb; 33(5):1563-72. PubMed ID: 22098778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
    Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P
    Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model.
    Zeb A; Qureshi OS; Yu CH; Akram M; Kim HS; Kim MS; Kang JH; Majid A; Chang SY; Bae ON; Kim JK
    Int J Pharm; 2017 Jun; 525(1):92-100. PubMed ID: 28428089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients.
    Singh R; Jadhav K; Kamboj R; Malhotra H; Ray E; Jhilta A; Dhir V; Verma RK
    Biomater Adv; 2024 Jun; 160():213853. PubMed ID: 38636119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies.
    Agrawal YO; Mahajan UB; Mahajan HS; Ojha S
    Int J Nanomedicine; 2020; 15():4763-4778. PubMed ID: 32753865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model.
    Haloi P; Lokesh BS; Chawla S; Konkimalla VB
    Drug Deliv; 2023 Dec; 30(1):2184307. PubMed ID: 36852696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
    Abdelbary G; Haider M
    Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats.
    Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S
    AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel hyaluronic acid-methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models.
    Tamura T; Higuchi Y; Kitamura H; Murao N; Saitoh R; Morikawa T; Sato H
    Arthritis Res Ther; 2016 Apr; 18():79. PubMed ID: 27039182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
    Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
    PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis.
    Kuncirova V; Ponist S; Mihalova D; Drafi F; Nosal R; Acquaviva A; Gardi C; Harmatha J; Hradkova I; Bauerova K
    Fundam Clin Pharmacol; 2014 Dec; 28(6):616-26. PubMed ID: 24920394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
    Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
    Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines.
    Sun Y; Yao Y; Ding CZ
    Int Immunopharmacol; 2014 Jan; 18(1):135-41. PubMed ID: 24287449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-coated solid lipid nanoparticles enhance antirheumatic activity and reduce toxicity of methotrexate.
    Mirchandani Y; Patravale VB; Brijesh S
    Nanomedicine (Lond); 2022 Jul; 17(16):1099-1114. PubMed ID: 36178114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis.
    Gu Y; Tang X; Yang M; Yang D; Liu J
    Int J Pharm; 2019 Jan; 554():235-244. PubMed ID: 30423415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.